Penumbra (PEN) Capital Expenditures Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.31% |
| Dec 31, 2025 | 104.81% |
| Sep 30, 2025 | -12.39% |
| Jun 30, 2025 | 18.32% |
| Mar 31, 2025 | 5.86% |
| Dec 31, 2024 | -263.27% |
| Sep 30, 2024 | 27.23% |
| Jun 30, 2024 | 60.19% |
| Mar 31, 2024 | 46.60% |
| Dec 31, 2023 | -98.03% |
| Sep 30, 2023 | 109.21% |
| Jun 30, 2023 | -40.48% |
| Mar 31, 2023 | 55.59% |
| Dec 31, 2022 | -9.06% |
| Sep 30, 2022 | 34.52% |
| Jun 30, 2022 | 15.35% |
| Mar 31, 2022 | 9.19% |
| Dec 31, 2021 | 37.41% |
| Sep 30, 2021 | -5.11% |
| Jun 30, 2021 | -54.20% |
| Mar 31, 2021 | 14.39% |
| Dec 31, 2020 | -15.11% |
| Sep 30, 2020 | -122.21% |
| Jun 30, 2020 | 103.92% |
| Mar 31, 2020 | 71.39% |
| Dec 31, 2019 | -14.94% |